Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Zymeworks, Lilly extend deal for new bi-specific immunotherapies on Azymetric platform By PBR Staff Writer
Zymeworks and Eli Lilly and Company have extended their existing licensing and collaboration agreement for development of an undisclosed number of new bi-specific antibody therapeutics using Zymeworks’ Azymetric platform.
Automation > IT & Software > News
iBio expands exclusive product collaboration with Novici Biotech iBio, a provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech (Novici) have agreed to broaden their commercial collaboration, currently focused on antibodies and certain vaccine products, to include iBio's proprietary IBIO-CFB03 product for idiopathic pulmonary fibrosis, systemic sclerosis and other fibrotic diseases.
Automation > IT & Software > News Plandai Biotechnology's technology could prove potent in battling alzheimers disease In the recently released preliminary results from Plandaí Biotechnology's human clinical trial that compared its green tea extract to a commercially available extract, Professor Anne Grobler and her team at North West University in South Africa proved that all 8 catechins found in the green tea plant were absorbed into the bloodstream of those using Phytofare Catechin Complex, including, the most potent catechin of the eight, epigallocatechin-3-gallate or EGCG.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
CEO of IPERION will speak at the ECA GMP Course March 2015
CEO Karel Bastiaanssen will give two presentations at the ECA GMP Course Cloud Computing and Outsourcing in a GxP Environment. The course will take place 12-13 March in Berlin, Germany, where the cloud service provider business and operating as a cloud service provider will be highlighted.
Automation > IT & Software > Press Releases
MedImmune’s Phase I OX40 agonist trial uses AgonOx’s OX40 platform
By PBR Staff Writer
US-based biotechnology firm AgonOx has announced that its OX40 platform is being used in AstraZeneca's global biologics research and development arm MedImmune’s Phase I trial of its humanized OX40 agonist, MEDI6383.
Automation > IT & Software > News
Aduro expands deal with Janssen to develop product candidates for lung cancer
By PBR Staff Writer
Aduro BioTech has entered into its second agreement with Janssen Biotech, granting an exclusive, worldwide license to certain product candidates designed to treat lung cancer and certain other cancers based on its novel LADD immunotherapy platform.
Automation > IT & Software > News
Immune Design, Sanofi Pasteur to develop herpes simplex virus therapy
By PBR Staff Writer
US-based clinical-stage immunotherapy firm Immune Design and Sanofi Pasteur have entered into a collaboration to develop a herpes simplex virus (HSV) immune therapy.
Automation > IT & Software > News
Nuvilex gets worldwide license for insulin-producing cells from University of Technology for use in developing diabetes treatment
Nuvilex has entered into a license with the University of Technology in Sydney, Australia (UTS), that grants Nuvilex the worldwide rights to use human insulin-producing cells, termed "Melligen" cells, developed by Prof. Ann Simpson and her colleagues at UTS for the development of a treatment for insulin-dependent (Type 1 or juvenile-onset) diabetes.
Automation > IT & Software > News
MorphoSys acquires Lanthio's lanthipeptide technology
By PBR Staff Writer
MorphoSys has exercised an option with Lanthio Pharma to acquire its lanthipeptide technology for drug discovery.
Automation > IT & Software > News
Orgenesis receives patent for potential cure for type 1 diabetes
Orgenesis, a leader in the emerging fields of cellular therapy and regenerative medicine, has announced that it has received a patent for the technology supporting its unique cell-based therapy, which is being developed as a potential cure for Type 1 Diabetes.
Automation > IT & Software > News
Portal Instruments completes landmark $11m series A financing for new drug delivery platform
Portal Instruments, a new dynamic, emerging leader in the development of innovative drug delivery systems, has completed a landmark $11m Series A financing led by Sanofi through its Sunrise initiative along with PBJ Capital (a Boston-based venture firm) and a major US medical device company.
Automation > IT & Software > News
FDA renews research contract with Symphony Health Solutions for outpatient prescription and drug utilization data
Symphony Health Solutions, a provider of high-value market research, analytics and technology solutions for healthcare and life science manufacturers, researchers, payers and providers, has announced that the company was awarded a $16.3m contract by the Food and Drug Administration (FDA) to provide estimates of the numbers of patients exposed to prescription drugs and the numbers of prescriptions dispensed nationwide in the outpatient setting.
Automation > IT & Software > News
Pharmaceutical organizations using new technologies for successful oncology product launches
Recent pharmaceutical product launches have had both noteworthy successes and failures – especially in the oncology therapeutic area.
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250